Andrew Moshfeghi, MD
Enriched profileVice Chair for Clinical Affairs and Associate Professor of Clinical Ophthalmology, Department of Ophthalmology, Keck School of Medicine · University of Southern California
Andrew Moshfeghi is Vice Chair for Clinical Affairs and Associate Professor of Clinical Ophthalmology, Department of Ophthalmology, Keck School of Medicine at University of Southern California. OpenAlex indexes 179 publications with 5,089 citations (h-index 36); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Andrew Moshfeghi, MD, is Vice Chair for Clinical Affairs and Associate Professor of Clinical Ophthalmology, Department of Ophthalmology, Keck School of Medicine at University of Southern California (USC Roski Eye Institute, Keck School of Medicine). The public record shows 179 publications with 5,089 citations (h-index 36), centered on Retinal Diseases and Treatments, Retinal and Optic Conditions, Retinal and Macular Surgery. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 14 companies.
- Most recent indexed publication: 2022 · PloS one
- Top research focus: Retinal Diseases and Treatments
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 77.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME
Sponsor: Andrew Moshfeghi, MD, MBA
Industry payments
Updated 27 Aug 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Ocular Therapeutix, Inc.Program year202531 payments$36,302openpaymentsdata.cms.gov ↗
- Apellis Pharmaceuticals, Inc.Program year20252 payments
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
75%alpha-Adrenergic Agonist27.6%Brimonidine Tartrate100%Part D≥11 patientsCorticosteroid23.7%Prednisolone Acetate100%Part D≥23 patientsMusculoskeletal
16%Cyclooxygenase Inhibitor16%Ketorolac Tromethamine100%Part D≥13 patientsCardiovascular
9%Beta blocker9%Timolol Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 27 Aug 2026
1 congress contribution (2024) across ADA per OpenAlex. The most recent:
- 560-P: Optimizing Vision Care for Diabetes Patients—Interprofessional Initiatives to Combat Clinical Inertia in the Management of Diabetic Retinopathy and Diabetic Macular Edema
ADA Scientific Sessions
ADA2024Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice.
Clinical ophthalmology (Auckland, N.Z.)
Article2020
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Enucleation207 citations2000
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/andrew-moshfeghi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/andrewmoshfeghi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Andrew-Moshfeghi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/usceye/p/CzJtOxZRJMV
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Ophthalmology360.com
Advisory board member, Ophthalmology 360
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmology360.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MBA
Health Sector Policy and Management, University of Miami Graduate School of Business Administration
2009verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ibt.usc.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keckmedicine.org ↗
- Board Certified
American Board of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keckmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Director
Vitreoretinal Surgery Fellowship Program, USC Roski Eye Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - Director
Clinical Trials Unit / Medical Director, USC Roski Eye Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Fellow
American Society of Retina Specialists (FASRS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ibt.usc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ibt.usc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ibt.usc.edu ↗
Secondary affiliations
appointments beyond the home institution- Affiliated faculty
USC Ginsburg Institute for Biomedical Therapeutics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ibt.usc.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keckmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinatoday.com ↗
- Guest
"Anti-VEGF, A Biography: Part 2", New Retina Radio podcast (Eyetube)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eyetube.net ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California